Standard Biotools share price today

(LAB)

Standard Biotools share price is $1.77 & ₹151.88 as on 7 Jan 2025, 2.30 'hrs' IST

$1.77

▲

-0.05

(-2.75%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Standard Biotools share price in Dollar and Rupees. Guide to invest in Standard Biotools stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Standard Biotools, along with analyst recommendations, forecasts, and comprehensive financials.

Standard Biotools share price movements

Today's Low: $1.75
Today's High: $1.83
$1.77
1.13%
Downside
Day's Volatility :4.37%
Upside
3.28%
52 Weeks Low: $1.21
52 Weeks High: $3.04
$1.77
31.64%
Downside
52 Weeks Volatility :60.2%
Upside
41.78%

Standard Biotools Returns

Period	Standard Biotools Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	1.11%	-8.4%	0.0%
6 Months	-1.09%	-3.8%	0.0%
1 Year	-14.15%	-0.1%	0.0%
3 Years	-42.77%	2.9%	-19.8%

Standard Biotools Key Statistics

in dollars & INR

Previous Close	$1.82
Open	$1.82
Today's High	$1.83
Today's Low	$1.75
Market Capitalization	$651.5M
Today's Volume	$676.6K
52 Week High	$3.04
52 Week Low	$1.21
Revenue TTM	$155.9M
EBITDA	$-114.3M
Earnings Per Share (EPS)	$-0.69
Profit Margin	-79.92%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-37.25%

How to invest in Standard Biotools from India?

It is very easy for Indian residents to invest directly in Standard Biotools from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Standard Biotools stock in both Indian Rupees (INR) and US Dollars (USD). Search for Standard Biotools or LAB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Standard Biotools or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Standard Biotools shares which would translate to 0.485 fractional shares of Standard Biotools as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Standard Biotools, in just a few clicks!

Returns in Standard Biotools for Indian investors in Rupees

Investment Value

₹1,00,000

Standard Biotools investment value today

Current value as on today

₹86,713

Returns

₹13,287

(-13.29%)

Returns from Standard Biotools Stock

₹16,509 (-16.51%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Standard Biotools

21%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Standard Biotools on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 21% more investors are searching Standard Biotools in the last 30 days versus the previous period.

Analyst Recommendation on Standard Biotools

Buy

83%Buy

16%Hold

0%Sell

Based on 6 Wall street analysts offering stock ratings for Standard Biotools(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Standard Biotools

What analysts predicted

Upside of 74.2%

Current:

$1.77

Target:

$3.08

Insights on Standard Biotools

Price Movement
In the last 7 days, LAB stock has moved up by 2.8%
Increasing Revenue
Revenue is up for the last 2 quarters, 37.20M → 44.96M (in $), with an average increase of 17.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -45.71M → -26.93M (in $), with an average increase of 69.7% per quarter
LAB vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 58.6%
LAB vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 157.1%
Price to Sales
ForLAB every $1 of sales, investors are willing to pay $3.3, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Standard Biotools Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$113.0M	↑ 10.82%
Net Income	$-59.0M	↓ 2.51%
Net Profit Margin	-52.24%	↑ 7.14%

	FY19	Y/Y Change
Revenue	$117.2M	↑ 3.79%
Net Income	$-64.8M	↑ 9.79%
Net Profit Margin	-55.26%	↓ 3.02%

	FY20	Y/Y Change
Revenue	$138.1M	↑ 17.83%
Net Income	$-53.0M	↓ 18.17%
Net Profit Margin	-38.38%	↑ 16.88%

	FY21	Y/Y Change
Revenue	$130.6M	↓ 5.47%
Net Income	$-59.2M	↑ 11.73%
Net Profit Margin	-45.36%	↓ 6.98%

	FY22	Y/Y Change
Revenue	$97.9M	↓ 24.99%
Net Income	$-190.1M	↑ 220.91%
Net Profit Margin	-194.08%	↓ 148.72%

	FY23	Y/Y Change
Revenue	$106.3M	↑ 8.57%
Net Income	$-74.7M	↓ 60.73%
Net Profit Margin	-70.21%	↑ 123.87%

	Q2 FY23	Q/Q Change
Revenue	$27.7M	↑ 10.14%
Net Income	$-17.0M	↑ 1.17%
Net Profit Margin	-61.59%	↑ 5.46%

	Q3 FY23	Q/Q Change
Revenue	$25.4M	↓ 8.31%
Net Income	$-21.0M	↑ 23.22%
Net Profit Margin	-82.77%	↓ 21.18%

	Q4 FY23	Q/Q Change
Revenue	$28.2M	↑ 11.12%
Net Income	$-19.8M	↓ 5.82%
Net Profit Margin	-70.16%	↑ 12.61%

	Q1 FY24	Q/Q Change
Revenue	$45.5M	↑ 61.56%
Net Income	$-32.2M	↑ 62.61%
Net Profit Margin	-70.61%	↓ 0.45%

	Q2 FY24	Q/Q Change
Revenue	$37.2M	↓ 18.3%
Net Income	$-45.7M	↑ 42.17%
Net Profit Margin	-122.88%	↓ 52.27%

	Q3 FY24	Q/Q Change
Revenue	$45.0M	↑ 20.87%
Net Income	$-26.9M	↓ 41.08%
Net Profit Margin	-59.9%	↑ 62.98%

	FY18	Y/Y Change
Profit	$61.6M	↑ 18.6%

	FY19	Y/Y Change
Profit	$64.3M	↑ 4.27%

	FY20	Y/Y Change
Profit	$83.3M	↑ 29.63%

	FY21	Y/Y Change
Profit	$77.3M	↓ 7.27%

	FY22	Y/Y Change
Profit	$37.1M	↓ 52.05%

	FY23	Y/Y Change
Profit	$50.5M	↑ 36.16%

	Q2 FY23	Q/Q Change
Profit	$13.6M	↑ 12.19%

	Q3 FY23	Q/Q Change
Profit	$11.2M	↓ 18.0%

	Q4 FY23	Q/Q Change
Profit	$13.4M	↑ 19.75%

	Q1 FY24	Q/Q Change
Profit	$24.2M	↑ 81.09%

	Q2 FY24	Q/Q Change
Profit	$14.9M	↓ 38.37%

	Q3 FY24	Q/Q Change
Profit	$23.3M	↑ 56.03%

	FY18	Y/Y Change
Operating Cash Flow	$-25.2M	↑ 4.58%
Investing Cash Flow	$4.7M	↓ 73.28%
Financing Cash Flow	$57.7M	↑ 98.85%

	FY19	Y/Y Change
Operating Cash Flow	$-35.2M	↑ 39.72%
Investing Cash Flow	$-39.3M	↓ 932.82%
Financing Cash Flow	$2.8M	↓ 95.16%

	FY20	Y/Y Change
Operating Cash Flow	$-15.4M	↓ 56.21%
Investing Cash Flow	$40.0M	↓ 201.71%
Financing Cash Flow	$20.9M	↑ 647.56%

	FY21	Y/Y Change
Operating Cash Flow	$-44.1M	↑ 185.79%
Investing Cash Flow	$-11.9M	↓ 129.88%
Financing Cash Flow	$16.0M	↓ 23.48%

	FY22	Y/Y Change
Operating Cash Flow	$-89.4M	↑ 102.83%
Investing Cash Flow	$-88.1M	↑ 637.71%
Financing Cash Flow	$230.8M	↑ 1345.94%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.3M	↑ 9.95%
Investing Cash Flow	$40.1M	↓ 7.02%
Financing Cash Flow	$-2.1M	↓ 18.53%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-11.4M	↑ 22.33%
Investing Cash Flow	$33.4M	↓ 16.88%
Financing Cash Flow	$-1.2M	↓ 44.15%

Standard Biotools Technicals Summary

Sell

Neutral

Buy

Standard Biotools is currently in a neutral trading position according to technical analysis indicators.

Standard Biotools Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Standard Biotools Inc	-5.7%	-1.09%	-14.15%	-42.77%	-46.63%
Stryker Corporation	-5.14%	7.73%	20.51%	37.02%	70.83%
Boston Scientific Corp.	2.22%	18.53%	55.24%	113.84%	98.4%
Edwards Lifesciences Corp.	4.25%	-20.93%	-2.33%	-38.47%	-5.21%
Abbott Laboratories	-0.93%	11.99%	1.27%	-15.84%	31.69%
Medtronic Plc	-3.59%	5.29%	-6.49%	-23.36%	-31.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Standard Biotools Inc	NA	NA	NA	-0.21	-0.37	-0.15	NA	1.23
Stryker Corporation	38.59	38.59	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.82	73.82	1.62	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.0	28.0	6.67	2.54	0.19	0.11	NA	16.18
Abbott Laboratories	34.38	34.38	2.19	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.43	24.43	1.46	5.45	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Standard Biotools Inc	Buy	$651.5M	-46.63%	NA	-79.92%
Stryker Corporation	Buy	$137.3B	70.83%	38.59	16.34%
Boston Scientific Corp.	Buy	$131.6B	98.4%	73.82	11.26%
Edwards Lifesciences Corp.	Buy	$43.6B	-5.21%	28.0	65.86%
Abbott Laboratories	Buy	$196.2B	31.69%	34.38	13.99%
Medtronic Plc	Buy	$102.4B	-31.62%	24.43	12.06%

About Standard Biotools

fluidigm (nasdaq:fldm) develops, manufactures and markets microfluidic systems for growth markets in the life sciences and in applied markets. fluidigmâ€™s systems consist of instruments, software, integrated fluidic circuits (ifcs), high-performance assays for gene expression and genotyping, and primers for sample preparation for next-generation sequencing. fluidigm technology enables customers to perform thousands of sophisticated biochemical measurements in parallel on samples smaller than the content of a single cell, with nanoliter volumes of reagents, in half the area of a credit card. the companyâ€™s integrated customer solutions are designed to significantly simplify experimental workflows, increase throughput and reduce costs while delivering excellent data quality. based in south san francisco, fluidigm offers an exciting and collegial working environment with excellent compensation and benefits, including equity.

Organization	Standard Biotools
Employees	534
CEO	Dr. Michael Egholm Ph.D.
Industry	Technology

Management People of Standard Biotools

Name	Title
Dr. Michael Egholm Ph.D.	President, CEO & Director
Mr. Hanjoon Kim	Chief Financial Officer
Mr. Jonathan Mickelsen	VP & Chief Accounting Officer
David Holmes	Investor Relations
Mr. Sean Mackay	Chief Business Officer & Senior VP
Dr. Stephen A. Williams BS, MB, Ph.D.	Chief Medical Officer

Important FAQs about investing in Standard Biotools from India :

What is Standard Biotools share price today?

Standard Biotools share price today stands at $1.77, Open: $1.82 ; Previous Close: $1.82 ; High: $1.83 ; Low: $1.75 ; 52 Week High: $3.04 ; 52 Week Low: $1.21. The stock opens at $1.82, after a previous close of $1.82. The stock reached a daily high of $1.83 and a low of $1.75, with a 52-week high of $3.04 and a 52-week low of $1.21.

Can Indians buy Standard Biotools shares?

Yes, Indians can invest in the Standard Biotools (LAB) from India.

With INDmoney, you can buy Standard Biotools at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Standard Biotools at zero transaction cost.

How can I buy Standard Biotools shares from India?

It is very easy to buy Standard Biotools from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Standard Biotools be purchased?

Yes, you can buy fractional shares of Standard Biotools with INDmoney app.

What are the documents required to start investing in Standard Biotools stocks?

To start investing in Standard Biotools, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.